Skip to main content
Erschienen in: Reactions Weekly 1/2013

01.07.2013 | Case report

Brentuximab vedotin

Progressive multifocal leukoencephalopathy: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Bennett CL, et al. Progressive multifocal leucoencephalopathy (PML): A novel complication of brentuximab vedotin from the Southern Network on Adverse Reactions (SONAR) project. Journal of Clinical Oncology 31 (Suppl. 1): abstr. 151, No. 151, 20 May 2013 - Mexico Bennett CL, et al. Progressive multifocal leucoencephalopathy (PML): A novel complication of brentuximab vedotin from the Southern Network on Adverse Reactions (SONAR) project. Journal of Clinical Oncology 31 (Suppl. 1): abstr. 151, No. 151, 20 May 2013 - Mexico
Metadaten
Titel
Brentuximab vedotin
Progressive multifocal leukoencephalopathy: 3 case reports
Publikationsdatum
01.07.2013
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2013
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-013-4555-y

Weitere Artikel der Ausgabe 1/2013

Reactions Weekly 1/2013 Zur Ausgabe

Case report

Diclofenac

Case report

Cyclophosphamide

Case report

Magnesium oxide